John S Mengucci, the President & CEO of $CACI, sold 33 shares of the company on 09-15-2025 for an estimated $16,179. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.0% of their shares of this class of stock. Following this trade, they now own 111,678 shares of this class of $CACI stock.
$CACI Insider Trading Activity
$CACI insiders have traded $CACI stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $CACI stock by insiders over the last 6 months:
- JOHN S MENGUCCI (President & CEO) has made 0 purchases and 5 sales selling 10,175 shares for an estimated $5,014,482.
- WILLIAM L JEWS sold 1,036 shares for an estimated $494,607
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CACI Hedge Fund Activity
We have seen 293 institutional investors add shares of $CACI stock to their portfolio, and 366 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CLOSE ASSET MANAGEMENT LTD added 324,531 shares (+inf%) to their portfolio in Q2 2025, for an estimated $154,703,927
- CITADEL ADVISORS LLC added 255,369 shares (+1307.7%) to their portfolio in Q2 2025, for an estimated $121,734,402
- ALLIANCEBERNSTEIN L.P. added 232,834 shares (+799.2%) to their portfolio in Q2 2025, for an estimated $110,991,967
- BOSTON PARTNERS added 197,880 shares (+60.1%) to their portfolio in Q2 2025, for an estimated $94,329,396
- WESTWOOD HOLDINGS GROUP INC removed 186,693 shares (-73.1%) from their portfolio in Q2 2025, for an estimated $88,996,553
- WELLINGTON MANAGEMENT GROUP LLP removed 131,544 shares (-16.6%) from their portfolio in Q2 2025, for an estimated $62,707,024
- PROFICIO CAPITAL PARTNERS LLC removed 117,986 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $43,291,423
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CACI Congressional Stock Trading
Members of Congress have traded $CACI stock 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $CACI stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $50,000 on 04/08.
- REPRESENTATIVE KELLY MORRISON has traded it 3 times. They made 0 purchases and 3 sales worth up to $45,000 on 03/20.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$CACI Analyst Ratings
Wall Street analysts have issued reports on $CACI in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Stifel issued a "Buy" rating on 08/08/2025
- UBS issued a "Buy" rating on 08/08/2025
- Truist Securities issued a "Buy" rating on 07/24/2025
- William Blair issued a "Outperform" rating on 07/07/2025
- Barclays issued a "Overweight" rating on 04/29/2025
- Wells Fargo issued a "Overweight" rating on 04/28/2025
- Jefferies issued a "Buy" rating on 03/25/2025
To track analyst ratings and price targets for $CACI, check out Quiver Quantitative's $CACI forecast page.
$CACI Price Targets
Multiple analysts have issued price targets for $CACI recently. We have seen 7 analysts offer price targets for $CACI in the last 6 months, with a median target of $544.0.
Here are some recent targets:
- Noah Poponak from Goldman Sachs set a target price of $544.0 on 08/13/2025
- Gavin Parsons from UBS set a target price of $614.0 on 08/08/2025
- Jonathan Siegmann from Stifel set a target price of $600.0 on 08/08/2025
- Sheila Kahyaoglu from Jefferies set a target price of $535.0 on 08/06/2025
- Tobey Sommer from Truist Securities set a target price of $550.0 on 07/24/2025
- David Strauss from Barclays set a target price of $510.0 on 04/29/2025
- Matthew Akers from Wells Fargo set a target price of $513.0 on 04/28/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
